NCT06793397
ClinicalTrials.gov
- Trial ID
- T-ctgov-NCT06793397
- Registry
- ClinicalTrials.gov
- NCT number
- NCT06793397
- Asset
- CYB003
- Sponsor, as registered
- Cybin IRL Limited
- Phase
- PHASE3
- Indication
- Major Depressive Disorder (MDD);Depression in Adults;Depression - Major Depressive Disorder;Depression Disorders;Depression Disorder;Depression
- Status
- RECRUITING
- Start date
- 2025-12-10
- Primary completion
- 2027-03-18
- Registered countries
- Australia, Czechia, Germany, Greece, Ireland, Poland, United Kingdom, United States
- Sites
- 69
The sponsor's registered location list, which states intent rather than approval.
clinicaltrials.govctgov registryverified 2026-08-31
Notes on the record
Fields read from the ClinicalTrials.gov v2 API record. countries is the distinct country list across all registered locations; site_count is the number of location entries, which counts a country once per site, not once per country.
Company
Through CYB003: Cybin
Cited in
Issues quoting NCT06793397 in their own text.